• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用中性腹膜透析液患者腹膜的形态学特征

Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution.

作者信息

Hamada Chieko, Honda Kazuho, Kawanishi Kunio, Nakamoto Hirotaka, Ito Yasuhiko, Sakurada Tsutomu, Tanno Yudo, Mizumasa Toru, Miyazaki Masanobu, Moriishi Misaki, Nakayama Masaaki

机构信息

Division of Nephrology, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan,

出版信息

J Artif Organs. 2015 Sep;18(3):243-50. doi: 10.1007/s10047-015-0822-4. Epub 2015 Feb 14.

DOI:10.1007/s10047-015-0822-4
PMID:25680950
Abstract

Peritoneal dialysis solution (PDS) plays a role in functional and morphological damage to the peritoneum. This study aimed to clarify the effect of neutral PDS in preventing morphological changes by assessing peritoneal damage and comparing morphological alterations between PD patients treated with neutral PDS and acidic PDS. Sixty-one patients participated from seven hospitals. All patients were treated with neutral PDS excluding icodextrin, during their entire PD treatment, and experienced no episode of peritonitis. The thickness of submesothelial compact (SMC) zone and the presence of vasculopathy in the anterior parietal abdominal peritoneum were assessed. The impact of icodextrin, hybrid therapy, and peritoneal rest and lavage in morphological alterations were determined. There was no significant difference in the average SMC thickness between neutral and acidic PDS. The vessel patency in patients using neutral PDS was significantly higher compared to that in acidic PDS at any time during PD. There were no significant suppressive effects from interventions or use of icodextrin with respect to peritoneal morphological injury. A monolayer of mesothelial cell was observed in approximately half the patients, especially in their receiving lavage patients. Neutral PDS, accompanied by other preventive approaches against peritoneal injury, might suppress the development of peritoneal morphological alterations.

摘要

腹膜透析液(PDS)在腹膜的功能和形态损伤中起作用。本研究旨在通过评估腹膜损伤并比较接受中性PDS和酸性PDS治疗的腹膜透析(PD)患者之间的形态学改变,来阐明中性PDS在预防形态学变化方面的作用。来自七家医院的61名患者参与了研究。所有患者在整个PD治疗期间均接受不含艾考糊精的中性PDS治疗,且未发生腹膜炎。评估了腹前壁腹膜间皮下致密(SMC)区的厚度以及血管病变情况。确定了艾考糊精、联合治疗以及腹膜休息和灌洗对形态学改变的影响。中性PDS和酸性PDS之间的平均SMC厚度无显著差异。在PD期间的任何时间,使用中性PDS的患者的血管通畅率均显著高于使用酸性PDS的患者。干预措施或使用艾考糊精对腹膜形态学损伤没有显著的抑制作用。在大约一半的患者中观察到单层间皮细胞,尤其是在接受灌洗的患者中。中性PDS与其他预防腹膜损伤的方法一起,可能会抑制腹膜形态学改变的发展。

相似文献

1
Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution.使用中性腹膜透析液患者腹膜的形态学特征
J Artif Organs. 2015 Sep;18(3):243-50. doi: 10.1007/s10047-015-0822-4. Epub 2015 Feb 14.
2
Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.腹膜透析液对人腹膜间皮细胞生长因子及细胞外基质蛋白分泌的影响。
Perit Dial Int. 2002 Mar-Apr;22(2):171-7.
3
Relationship between laparoscopic and microscopic findings of peritoneum in peritoneal dialysis patients.腹膜透析患者腹膜腹腔镜和显微镜检查结果的关系。
J Artif Organs. 2023 Jun;26(2):134-143. doi: 10.1007/s10047-022-01344-1. Epub 2022 Aug 3.
4
Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.中性 pH 值和低葡萄糖降解产物透析液可诱导腹膜透析儿童腹膜的主要早期改变。
Kidney Int. 2018 Aug;94(2):419-429. doi: 10.1016/j.kint.2018.02.022.
5
Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells.艾考糊精对整合素介导的腹膜间皮细胞创伤愈合的影响。
Life Sci. 2012 Jun 14;90(23-24):917-23. doi: 10.1016/j.lfs.2012.04.036. Epub 2012 Apr 27.
6
Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.7.5%艾考糊精诱导的间皮发育异常变化和脂质过氧化
Nephron. 2002 Sep;92(1):142-55. doi: 10.1159/000064482.
7
Influence of pH-neutral peritoneal dialysis solution.pH 中性腹膜透析液的影响。
Adv Perit Dial. 2002;18:68-71.
8
Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells.基于艾考糊精和葡萄糖的腹膜透析液对人腹膜间皮细胞急慢性影响的比较
Int J Artif Organs. 2007 Dec;30(12):1075-82. doi: 10.1177/039139880703001207.
9
Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.基于艾考糊精的透析液对腹膜瘦素清除率的影响。
Perit Dial Int. 2003 Jan-Feb;23(1):89-91.
10
Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.在慢性透析模型中,腹膜透析液会扰乱腹膜细胞凋亡与增殖的平衡。
Adv Perit Dial. 2001;17:53-7.

引用本文的文献

1
Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis.腹膜透析中腹膜纤维化和腹膜功能障碍的病理生理机制。
Int J Mol Sci. 2024 Aug 7;25(16):8607. doi: 10.3390/ijms25168607.
2
Role of endothelial hyaluronan in peritoneal membrane transport and disease conditions during peritoneal dialysis.内皮细胞透明质酸在腹膜透析过程中腹膜膜转运和疾病状态中的作用。
Sci Rep. 2024 Mar 28;14(1):7412. doi: 10.1038/s41598-024-58148-x.
3
Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy.

本文引用的文献

1
Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.在接受腹膜透析的患者中,葡萄糖降解产物含量低的中性溶液与较少的腹膜纤维化和血管硬化有关。
Perit Dial Int. 2013 May-Jun;33(3):242-51. doi: 10.3747/pdi.2011.00270. Epub 2012 Nov 1.
2
Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.长期使用生物相容性好的透析液进行腹膜透析后的腹膜形态:日本的近期临床实践。
Perit Dial Int. 2012 Mar-Apr;32(2):159-67. doi: 10.3747/pdi.2010.00234. Epub 2011 Jul 31.
3
腹膜透析并糖皮质激素治疗患者发生包裹性腹膜硬化症。
Intern Med. 2023 Nov 1;62(21):3203-3207. doi: 10.2169/internalmedicine.1760-23. Epub 2023 Jul 12.
4
Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan.包裹性腹膜硬化症的病理生理学:过去三十年在日本的发现带来的启示。
Clin Exp Nephrol. 2023 Sep;27(9):717-727. doi: 10.1007/s10157-023-02360-y. Epub 2023 Jun 6.
5
Relationship between laparoscopic and microscopic findings of peritoneum in peritoneal dialysis patients.腹膜透析患者腹膜腹腔镜和显微镜检查结果的关系。
J Artif Organs. 2023 Jun;26(2):134-143. doi: 10.1007/s10047-022-01344-1. Epub 2022 Aug 3.
6
How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease-what can we learn for future treatment?腹膜透析如何改变慢性肾病患儿的腹膜和血管系统——我们能从中学到什么以用于未来的治疗?
Mol Cell Pediatr. 2022 May 5;9(1):9. doi: 10.1186/s40348-022-00141-3.
7
Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis.低 GDP、中性 pH 值的溶液可在长期腹膜透析过程中保护腹膜内皮细胞糖萼。
Clin Exp Nephrol. 2021 Sep;25(9):1035-1046. doi: 10.1007/s10157-021-02078-9. Epub 2021 May 17.
8
A disposable, ultra-fine endoscope for non-invasive, close examination of the intraluminal surface of the peritoneal dialysis catheter and peritoneal cavity.一种一次性使用的超细内窥镜,用于对腹膜透析导管和腹腔的腔内表面进行非侵入性的近距离检查。
Sci Rep. 2020 Oct 16;10(1):17565. doi: 10.1038/s41598-020-74129-2.
9
Outcomes of laparoscopic and open CAPD catheter placement: A single-center experience.腹腔镜与开放腹膜透析导管置入的结局:单中心经验
Surg Open Sci. 2019 May 24;1(1):20-24. doi: 10.1016/j.sopen.2019.05.003. eCollection 2019 Jul.
10
Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients.腹膜透析患者活检样本的病理诊断建议。
Pleura Peritoneum. 2017 Mar 1;2(1):3-15. doi: 10.1515/pp-2016-0028. Epub 2017 Mar 17.
2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis.
2009年日本透析治疗学会腹膜透析指南
Ther Apher Dial. 2010 Dec;14(6):489-504. doi: 10.1111/j.1744-9987.2010.00901.x.
4
Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients.定量评估腹膜透析患者腹膜形态变化。
Nephrol Dial Transplant. 2010 Oct;25(10):3379-85. doi: 10.1093/ndt/gfq194. Epub 2010 Apr 22.
5
The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.腹腔灌洗和间皮细胞面积在预防包裹性腹膜硬化症中的作用及其预后意义。
Perit Dial Int. 2010 May-Jun;30(3):343-52. doi: 10.3747/pdi.2008.00273. Epub 2010 Mar 25.
6
Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?生物相容性腹膜透析液:它们真的会影响治疗结果吗?
Pol Arch Med Wewn. 2009 Apr;119(4):242-7.
7
Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology.尿毒症、糖尿病及腹膜透析本身对腹膜硬化发病机制的影响:腹膜形态的定量研究
Clin J Am Soc Nephrol. 2008 May;3(3):720-8. doi: 10.2215/CJN.03630807. Epub 2008 Feb 13.
8
Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?慢性腹膜透析患者的葡萄糖降解产物(GDP's)与腹膜变化:新型透析液能否预防这些变化?
Int Urol Nephrol. 2005;37(2):409-18. doi: 10.1007/s11255-004-1392-1.
9
Advanced glycation end-products and peritoneal sclerosis.晚期糖基化终末产物与腹膜硬化
Semin Nephrol. 2004 Sep;24(5):502-5. doi: 10.1016/j.semnephrol.2004.06.027.
10
Morphologic changes in the peritoneal membrane of patients with renal disease.肾病患者腹膜的形态学变化。
J Am Soc Nephrol. 2002 Feb;13(2):470-479. doi: 10.1681/ASN.V132470.